BML, Inc. (4694.T)

JPY 2953.0

(-0.03%)

EBITDA Summary of BML, Inc.

  • BML, Inc.'s latest annual EBITDA in 2023 was 16.41 Billion JPY , down -47.94% from previous year.
  • BML, Inc.'s latest quarterly EBITDA in 2024 Q1 was 4.19 Billion JPY , up 26.81% from previous quarter.
  • BML, Inc. reported an annual EBITDA of 30.57 Billion JPY in 2022, down -46.45% from previous year.
  • BML, Inc. reported an annual EBITDA of 56.25 Billion JPY in 2021, up 117.18% from previous year.
  • BML, Inc. reported a quarterly EBITDA of 2.83 Billion JPY for 2023 Q3, up 12.45% from previous quarter.
  • BML, Inc. reported a quarterly EBITDA of 3.18 Billion JPY for 2023 Q4, up 12.23% from previous quarter.

Annual EBITDA Chart of BML, Inc. (2023 - 2004)

Historical Annual EBITDA of BML, Inc. (2023 - 2004)

Year EBITDA EBITDA Growth
2023 16.41 Billion JPY -47.94%
2022 30.57 Billion JPY -46.45%
2021 56.25 Billion JPY 117.18%
2020 26.49 Billion JPY 71.37%
2019 15.34 Billion JPY -5.5%
2018 16.21 Billion JPY 7.06%
2017 15.14 Billion JPY 1.35%
2016 14.71 Billion JPY 1.86%
2015 14.61 Billion JPY 8.51%
2014 13.21 Billion JPY -4.55%
2013 14.12 Billion JPY 10.5%
2012 12.77 Billion JPY 14.68%
2011 11.69 Billion JPY -2.75%
2010 11.29 Billion JPY 1.24%
2009 11.11 Billion JPY 13.76%
2008 9.76 Billion JPY 23.22%
2007 7.74 Billion JPY 9.86%
2006 8.08 Billion JPY -10.87%
2005 8.02 Billion JPY 8.11%
2004 7.6 Billion JPY 0.0%

Peer EBITDA Comparison of BML, Inc.

Name EBITDA EBITDA Difference
Shin Nippon Biomedical Laboratories, Ltd. 8.98 Billion JPY -82.815%
DNA Chip Research Inc. -217 Million JPY 7666.359%
Cosmo Bio Company,Limited 669 Million JPY -2354.26%
H.U. Group Holdings, Inc. 13.64 Billion JPY -20.312%
FALCO HOLDINGS Co., Ltd. 3.13 Billion JPY -424.234%
Human Metabolome Technologies, Inc. 306.48 Million JPY -5257.213%
Precision System Science Co., Ltd. -661.75 Million JPY 2581.148%